<table id="t10" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 10     Drug Interactions: Changes in Pharmacokinetic Parameters for Coadministered Drug in the Presence of Tenofovir</caption>
<col align="left" valign="middle" width="21%"></col>
<col align="center" valign="middle" width="21%"></col>
<col align="center" valign="middle" width="4%"></col>
<col align="center" valign="middle" width="18%"></col>
<col align="center" valign="middle" width="18%"></col>
<col align="center" valign="middle" width="18%"></col>
<thead>
<tr>
<th rowspan="2" stylecode="Lrule Rrule">Coadministered Drug</th>
<th rowspan="2" stylecode="Rrule">Dose of Coadministered Drug (mg)</th>
<th rowspan="2" stylecode="Rrule">N</th>
<th colspan="3" stylecode="Rrule Botrule">% Change of Coadministered Drug Pharmacokinetic Parameters<footnote>Increase = ↑; Decrease = ↓; No Effect = ⇔; NA = Not Applicable</footnote>
<br/>(90% CI)</th>
</tr>
<tr>
<th align="center" stylecode="Rrule">C<sub>max</sub>
</th>
<th stylecode="Rrule">AUC</th>
<th stylecode="Rrule">C<sub>min</sub>
</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Abacavir</td>
<td stylecode="Rrule">300 once</td>
<td stylecode="Rrule">8</td>
<td stylecode="Rrule">↑ 12<br/>(↓ 1 to ↑ 26)</td>
<td stylecode="Rrule">⇔</td>
<td stylecode="Rrule">NA</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Atazanavir<footnote id="ft10.1">Reyataz Prescribing Information</footnote>
</td>
<td stylecode="Rrule">400 once daily × 14 days</td>
<td stylecode="Rrule">34</td>
<td stylecode="Rrule">↓ 21<br/>(↓ 27 to ↓ 14)</td>
<td stylecode="Rrule">↓ 25<br/>(↓ 30 to ↓ 19)</td>
<td stylecode="Rrule">↓ 40<br/>(↓ 48 to ↓ 32)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Atazanavir<footnoteref idref="ft10.1"></footnoteref>
</td>
<td stylecode="Rrule">Atazanavir/Ritonavir<br/>300/100 once daily<br/>× 42 days</td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">↓ 28<br/>(↓ 50 to ↑ 5)</td>
<td stylecode="Rrule">↓ 25<footnote id="ft10.2">In HIV-infected subjects, addition of tenofovir DF to atazanavir 300 mg plus ritonavir 100 mg, resulted in AUC and C<sub>min</sub> values of atazanavir that were 2.3 and 4-fold higher than the respective values observed for atazanavir 400 mg when given alone.</footnote>
<br/>(↓ 42 to ↓ 3)</td>
<td stylecode="Rrule">↓ 23<footnoteref idref="ft10.2"></footnoteref>
<br/>(↓ 46 to ↑ 10)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Darunavir<footnote id="table10d">Prezista Prescribing Information.</footnote>
</td>
<td stylecode="Rrule">Darunavir/Ritonavir 300/100 mg once daily</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">↑ 16<br/>(↓ 6 to ↑ 42)</td>
<td stylecode="Rrule">↑ 21<br/>(↓ 5 to ↑ 54)</td>
<td stylecode="Rrule">↑ 24<br/>(↓ 10 to ↑ 69)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Didanosine<footnote>Videx EC Prescribing Information. Subjects received didanosine enteric-coated capsules.</footnote>
</td>
<td stylecode="Rrule">250 once, simultaneously with tenofovir DF and a light meal<footnote>373 kcal, 8.2 g fat</footnote>
</td>
<td stylecode="Rrule">33</td>
<td stylecode="Rrule">↓ 20<footnote id="ft10f">Compared with didanosine (enteric-coated) 400 mg administered alone under fasting conditions.</footnote>
<br/>(↓ 32 to ↓ 7)</td>
<td stylecode="Rrule">⇔<footnoteref idref="ft10f"></footnoteref>
</td>
<td stylecode="Rrule">NA</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Emtricitabine</td>
<td stylecode="Rrule">200 once daily × 7 days</td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">⇔</td>
<td stylecode="Rrule">⇔</td>
<td stylecode="Rrule">↑ 20<br/>(↑ 12 to ↑ 29)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Indinavir</td>
<td stylecode="Rrule">800 three times daily × 7 days</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">↓ 11<br/>(↓ 30 to ↑ 12)</td>
<td stylecode="Rrule">⇔</td>
<td stylecode="Rrule">⇔</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Entecavir</td>
<td stylecode="Rrule">1 mg once daily × 10 days</td>
<td stylecode="Rrule">28</td>
<td stylecode="Rrule">⇔</td>
<td stylecode="Rrule">↑ 13<br/>(↑ 11 to ↑ 15)</td>
<td stylecode="Rrule">⇔</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Lamivudine</td>
<td stylecode="Rrule">150 twice daily × 7 days</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">↓ 24<br/>(↓ 34 to ↓ 12)</td>
<td stylecode="Rrule">⇔</td>
<td stylecode="Rrule">⇔</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Lopinavir<br/>Ritonavir</td>
<td stylecode="Rrule">Lopinavir/Ritonavir 400/100 twice daily × 14 days</td>
<td stylecode="Rrule">24</td>
<td stylecode="Rrule">⇔<br/>⇔</td>
<td stylecode="Rrule">⇔<br/>⇔</td>
<td stylecode="Rrule">⇔<br/>⇔</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top">Saquinavir</td>
<td rowspan="2" stylecode="Rrule Botrule">Saquinavir/Ritonavir 1000/100 twice daily × 14 days</td>
<td rowspan="2" stylecode="Rrule Botrule">32</td>
<td stylecode="Rrule" valign="top">↑ 22<br/>(↑ 6 to ↑41)</td>
<td stylecode="Rrule" valign="top">↑ 29<footnote id="ft10.3">Increases in AUC and C<sub>min</sub> are not expected to be clinically relevant; hence no dose adjustments are required when tenofovir DF and ritonavir-boosted saquinavir are coadministered.</footnote>
<br/>(↑ 12 to ↑ 48)</td>
<td stylecode="Rrule" valign="top">↑ 47<footnoteref idref="ft10.3"></footnoteref>
<br/>(↑ 23 to ↑ 76)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Ritonavir</td>
<td stylecode="Rrule" valign="top">⇔</td>
<td stylecode="Rrule" valign="top">⇔</td>
<td stylecode="Rrule" valign="top">↑ 23<br/>(↑ 3 to ↑ 46)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Tacrolimus</td>
<td stylecode="Rrule">0.05 mg/kg twice daily × 7 days</td>
<td stylecode="Rrule">21</td>
<td stylecode="Rrule">⇔</td>
<td stylecode="Rrule">⇔</td>
<td stylecode="Rrule">⇔</td>
</tr>
<tr stylecode="Botrule">
<td rowspan="2" stylecode="Lrule Rrule">Tipranavir<footnote id="table10i">Aptivus Prescribing Information.</footnote>
</td>
<td stylecode="Rrule">Tipranavir/Ritonavir 500/100 twice daily</td>
<td stylecode="Rrule">22</td>
<td stylecode="Rrule">↓ 17<br/>(↓ 26 to ↓ 6)</td>
<td stylecode="Rrule">↓ 18<br/>(↓ 25 to ↓ 9)</td>
<td stylecode="Rrule">↓ 21<br/>(↓ 30 to ↓ 10)</td>
</tr>
<tr>
<td align="center" stylecode="Rrule">Tipranavir/Ritonavir 750/200 twice daily (23 doses)</td>
<td stylecode="Rrule">20</td>
<td stylecode="Rrule">↓ 11<br/>(↓ 16 to ↓ 4)</td>
<td stylecode="Rrule">↓ 9<br/>(↓ 15 to ↓ 3)</td>
<td stylecode="Rrule">↓ 12<br/>(↓ 22 to 0)</td>
</tr>
</tbody>
</table>